• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    126.34 Down 0.62(0.49%) Mar 6, 4:00PM EST
    |After Hours : 126.50 Up 0.16 (0.13%) Mar 6, 7:00PM EST
    Add to Portfolio
    Prev Close:126.96
    Open:126.84
    Bid:114.20 x 100
    Ask:126.50 x 400
    1y Target Est:134.58
    Beta:-0.7
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:124.78 - 126.96
    52wk Range:59.79 - 127.69
    Volume:1,581,081
    Avg Vol (3m):1,654,460
    Market Cap:30.59B
    P/E (ttm):N/A
    EPS (ttm):-3.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    VRTXDown 0.49%30.59B
    BMYDown 1.41%108.24B
    MRKDown 1.97%161.32B
    PTCTDown 2.19%2.34B

    Key Statistics

    Forward P/E (1 yr):32.23
    P/S (ttm):52.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Mar-15) :-0.74
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-2.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback